IPR

Topic 160 Industry Master

Topic 160 — Industry Deep-Dives Master and 17-Module Series Conclusion

This concluding topic of Module 17 — and indeed of the EXTENDED 17-MODULE / 160-TOPIC IPR series — consolidates the industry deep-dives master compendium. Module 17 has covered: PHARMACEUTICAL IP (Topic 153) — Section 3(d) anti-evergreening; Section 84 compulsory licensing; Section 107A Bolar; Novartis 2013; Natco-Bayer 2012; Bayer-UoI 2019; Aventis 2025; DPCO 2013; Doha 2001 + MC12 2022. TECH INDUSTRY IP (Topic 154) — Section 3(k) software framework; CRI Guidelines 2025; Ferid Allani 2019 technical effect; OpenTV 2023 business methods; Telefonaktiebolaget v. Lava 2024 ₹244 CRORE; InterDigital v. Xiaomi anti-suit; Engineering Analysis 2021. BIOTECHNOLOGY IP (Topic 155) — Section 3(j) plants/animals; PPV&FR Act 2001 strong farmers rights; BD Act 2002 + Section 6 NBA approval; TKDL 290,000+ entries; Monsanto-Nuziveedu 2019; Nagoya 2014; Cartagena 2003; vaccine framework. FMCG IP (Topic 156) — multi-IP framework; Trade Dress (ITC-Britannia 2017; Christian Louboutin 2018; Cadbury purple); Pidilite 2024 ₹50L; Cadila 2001 + Pernod Ricard 2025 INSC 981; Mars-Cadbury 2025 mediation; Section 11(6) well-known; 600+ Indian GIs; Microfibres 50-article rule; Consumer Protection Act 2019. BANKING + FINTECH IP (Topic 157) — Section 3(k) navigation; CRI Guidelines 2025; Ab Initio 2024 blockchain technical effect; Engineering Analysis 2021 software; UPI 14B+ monthly; PSS Act 2007; India Stack; Section 115BBH cryptocurrency 30% tax; RBI v. IMAI 2020; CBDC; DPDP Act 2023; Hermès NFT 2023. HEALTHCARE + MEDICAL DEVICES IP (Topic 158) — Section 3(i) medical methods exclusion; D&C Act 1940; Medical Devices Rules 2017 Class A/B/C/D; CDSCO + DCGI; Telemedicine Practice Guidelines 2020; Ayushman Bharat Digital Mission; AI medical applications via CRI Guidelines 2025; Aventis 2025; Novartis 2013; Natco-Bayer 2012. EDUCATION + EDTECH IP (Topic 159) — Section 52(1)(i) educational fair dealing (Cambridge UP 2016); Section 52(1)(zb) Marrakesh 2014; Section 17(c) work for hire; Section 17(d) NCERT government work; CRI Guidelines 2025 for AI tutoring; IT Rules 2021; Section 79 safe harbour; Cinematograph (Amendment) Act 2023; DPDP Act 2023 student data; ANI v. OpenAI pending; Stephen Thaler 2025 AI authorship. The COMPLETE 17-MODULE / 160-TOPIC SERIES now provides judiciary aspirants with comprehensive Indian IPR jurisprudence framework — from foundations (M1-M2), through doctrinal pillars (M3-M8), specialised areas (M9-M11), foundational cases (M12), international framework (M13), strategic + procedural (M14-M15), workshop mastery (M16), and INDUSTRY DEEP-DIVES (M17). Recent watershed cases continue to shape framework: TELEFONAKTIEBOLAGET v. LAVA (2024:DHC:2698) ₹244 CRORE; AVENTIS v. ALGREAT (3 February 2025) ₹5L+4 weeks; PIDILITE v. PREMIER (2024) ₹50L; PERNOD RICARD v. KARANVEER (2025 INSC 981); UTV v. 1337X.to (2019); ANIL KAPOOR (2023); ARJAN DUGAL (2025); TOSHIBA (2024); MARS-CADBURY (2025); WOW MOMO (2025); VISHAL SOLANKE (2025:BHC-OS:4952); STEPHEN THALER (2025); CALEB SURESH MOTUPALLI (2025); ENGINEERING ANALYSIS (2021); OPENTV (2023:DHC:3305); BAYER-UoI (2019); NATCO-BAYER (2012); NOVARTIS (2013); MONSANTO-NUZIVEEDU (2019); CAMBRIDGE UP (2016). India's strategic position: TRIPS-compliant + flexibilities-preserving + South-South cooperation + strategic autonomy + industry-leading. The 17-MODULE / 160-TOPIC SERIES IS NOW COMPLETE.

1. The Complete 17-Module IPR Series

M1

FOUNDATIONS

IP basics

M2

COPYRIGHT

literary + artistic

M3

TRADEMARK

brand protection

M4

PATENT

inventions

M5

DESIGNS

industrial designs

M6

GIs

geographical indications

M7

TRADE SEC

confidential information

M8

PLANT/BIOD

plants + biodiversity + TK

M9

EMERGING

AI/blockchain/biotech

M10

ENFORCE

enforcement

M11

INTERSECT

intersections

M12

CASES

landmark cases

M13

INTL

international framework

M14

STRATEGY

strategic + future

M15

PROCEDURE

procedural + specialised

M16

WORKSHOP

practical IP skills

M17

INDUSTRY

industry deep-dives

2. Module 17 — Industry Deep-Dives Compendium

Topic

Industry

Key Framework

153

Pharmaceutical IP

Section 3(d) + 84 + 107A + 92; Novartis 2013; Natco-Bayer 2012; Bayer-UoI 2019; DPCO 2013.

154

Tech Industry IP

Section 3(k) + CRI Guidelines 2025; Ferid Allani 2019; Telefonaktiebolaget v. Lava 2024 ₹244 CRORE; Engineering Analysis 2021.

155

Biotechnology IP

Section 3(j) + PPV&FR 2001 + BD Act 2002 + Section 6 NBA; TKDL; Monsanto-Nuziveedu 2019; Nagoya + Cartagena Protocols.

156

FMCG IP

Multi-IP framework; Trade Dress (ITC-Britannia 2017; Christian Louboutin 2018; Cadbury purple); Pidilite 2024 ₹50L; Cadila + Pernod Ricard; 600+ GIs.

157

Banking + FinTech IP

Section 3(k) navigation; PSS Act 2007; UPI; India Stack; Section 115BBH crypto 30%; RBI v. IMAI 2020; CBDC; DPDP Act 2023.

158

Healthcare + Medical Devices IP

Section 3(i) medical methods; D&C Act 1940; Medical Devices Rules 2017 Class A/B/C/D; CDSCO; Telemedicine Guidelines 2020; Ayushman Bharat Digital.

159

Education + EdTech IP

Section 52(1)(i) educational fair dealing (Cambridge UP 2016); Marrakesh 2014; NCERT government work; IT Rules 2021; Section 79 safe harbour.

160

M17 Master Closer

Series-wide compendium; complete 17-module / 160-topic framework.

3. Top 30 Industry Deep-Dive Quick Recall

Top 30 Module 17 Quick Recall

1. India largest generic pharma supplier; "Pharmacy of the World".

2. Section 3(d) — anti-evergreening (Novartis 2013).

3. Therapeutic efficacy enhancement required (not bioavailability alone).

4. Section 84 — compulsory licensing (Natco-Bayer 2012; 6% royalty).

5. Section 107A — broad Bolar exception (Bayer-UoI 2019; includes export).

6. India 2nd largest telecom; $250B+ IT services.

7. CRI Guidelines 2025 (29 July 2025) — three-step test.

8. Ferid Allani 2019:DHC:6944 — TECHNICAL EFFECT TEST.

9. OpenTV 2023:DHC:3305 — business methods absolute bar.

10. Telefonaktiebolaget v. Lava 2024:DHC:2698 — ₹244 CRORE damages (March 2024).

11. Engineering Analysis 2021 — software NOT royalty under DTAAs.

12. Section 3(j) — plants/animals/varieties not patentable; microorganisms patentable.

13. PPV&FR Act 2001 — strong farmers rights (NOT UPOV 1991).

14. BD Act 2002 + Section 6 NBA approval mandatory.

15. TKDL 290,000+ entries; turmeric, neem, basmati cancellations.

16. India FMCG: $200B+; 4th largest globally.

17. Multi-IP for FMCG: TM + Designs + Trade Dress + Trade Secrets.

18. ITC v. Britannia 2017 — trade dress framework.

19. Pidilite v. Premier 2024 — ₹50L damages.

20. Cadila 2001 + Pernod Ricard 2025 — composite test.

21. 600+ Indian GIs; Basmati, Darjeeling, Kolhapuri.

22. India fintech: 3rd largest globally; UPI 14B+ monthly.

23. PSS Act 2007 + RBI Act 1934 + Banking Regulation 1949.

24. India Stack: Aadhaar + UPI + DigiLocker.

25. Section 115BBH — 30% tax on cryptocurrency (introduced 2022).

26. RBI v. IMAI 2020 — banking ban lifted on crypto.

27. India healthcare: $370B; 10%+ CAGR.

28. Section 3(i) — medical methods NOT patentable; apparatus patentable.

29. India EdTech: $10B+; 250M+ students.

30. Section 52(1)(i) — educational fair dealing (Cambridge UP 2016).

4. The Complete 160-Topic IPR Series — Top 60 Series Recall

Top 60 Series Recall (M1-M17)

1. Patents Act 1970 + Patents (Amendment) Rules 2024 effective 15 March 2024.

2. Trade Marks Act 1999 + Trade Marks Rules 2017.

3. Copyright Act 1957 + Copyright (Amendment) Act 2012 + Copyright Rules 2013.

4. Designs Act 2000 + Designs (Amendment) Rules 2021.

5. Geographical Indications of Goods Act 1999.

6. PPV&FR Act 2001 — plant variety + strong farmers rights.

7. Biological Diversity Act 2002 — Section 6 NBA approval.

8. Section 3(d) Patents Act — anti-evergreening (Novartis 2013).

9. Section 3(i) — medical methods NOT patentable.

10. Section 3(j) — plants/animals NOT patentable; microorganisms YES.

11. Section 3(k) — software/algorithms NOT patentable "as such".

12. Section 84 — compulsory licensing (Natco-Bayer 2012).

13. Section 107A — Bolar exception (Bayer-UoI 2019 broad).

14. Section 11(6) + Rule 124 — well-known marks.

15. 45 Nice Classes; Madrid Protocol since 8 July 2013.

16. Section 52 Copyright — specific fair dealing categories.

17. Section 38, 38A, 38B — performers rights (2012).

18. Section 65A + 65B — TPMs + RMIs (2012).

19. Section 17(c) — work for hire.

20. Section 19 — assignment in writing + signed.

21. Cinematograph (Amendment) Act 2023 — effective 4 August 2023.

22. IT Rules 2021 — effective 25 February 2021.

23. CRI Guidelines 2025 — three-step test (29 July 2025).

24. Tribunals Reforms Act 2021 — IPAB abolition.

25. Delhi HC IPD (2021); Madras HC IPD (April 2023).

26. UTV v. 1337X.to 2019 — pioneer dynamic injunctions.

27. Telefonaktiebolaget v. Lava 2024 — ₹244 CRORE (March 2024).

28. Aventis v. Algreat 2025 — ₹5L + 4 weeks imprisonment.

29. Pidilite v. Premier 2024 — ₹50L damages.

30. Pernod Ricard 2025 INSC 981 — composite test reaffirmed.

31. Anil Kapoor 2023 — personality rights against AI.

32. Arjan Dugal 2025 — combined IP ex parte.

33. Toshiba v. Tosiba 2024 — 50-year trademark seniority.

34. Mars-Cadbury 2025 — Mediation Act 2023 settlement.

35. WOW Momo 2025 — composite marks + secondary meaning.

36. Vishal Solanke 2025:BHC-OS:4952 — examination/opposition distinct.

37. Stephen Thaler 2025 — AI authorship rejected.

38. Caleb Suresh Motupalli 2025 — sufficiency strict.

39. Engineering Analysis 2021 — software royalty taxation.

40. OpenTV 2023:DHC:3305 — business methods absolute bar.

41. Cadila 2001 — 7-factor composite test.

42. Niranjan Shankar 1967 — during employment.

43. Krishna Murgai 1981 — post-employment non-compete INVALID.

44. American Express v. Aitken 2006 — post-employment confidentiality.

45. Cambridge UP 2016 — educational fair dealing.

46. Microfibres v. Girdhar 2009 — 50-article rule (Section 15 Designs Act).

47. Mediation Act 2023 — effective 24 January 2024.

48. DPDP Act 2023 — effective February 2025.

49. Income Tax Act 2025 — effective 1 April 2026.

50. India member: Berne (1928); Marrakesh (2014); Beijing (2020); Madrid (2013); Hague Geneva (2014); PCT (1998); Paris (1998).

51. India NOT member: WCT, WPPT, UPOV.

52. India lead: Doha 2001; co-lead MC12 2022; lead WIPO Treaty 2024.

53. CCI Penalty Guidelines 2024 — global turnover.

54. Customs IPR Enforcement Rules 2018 — patents removed 2018.

55. India strategic: TRIPS-compliant + flexibilities + South-South + autonomy.

56. Industry leadership: pharma + IT + telecom + biotech + FMCG + fintech + healthcare + EdTech.

57. Section 115BBH — cryptocurrency 30% (2022); Section 194S — 1% TDS.

58. RBI v. IMAI 2020 — crypto banking ban lifted.

59. Monsanto-Nuziveedu 2019 — Bt cotton framework; Section 3(j) reaffirmed.

60. ANI v. OpenAI 2024 — judgment reserved 2025; AI training framework.

5. Complete Series Coverage — Module by Module

Module

Topics

Coverage

M1 — Foundations

1-14

IP basics; constitutional framework; international foundations.

M2 — Copyright

15-27

Literary + artistic + musical + cinematograph + sound recording; performers rights; TPMs/RMIs.

M3 — Trademark

28-48

Brand protection; Sections 9, 11, 18, 21, 23, 25, 47; well-known marks; Madrid.

M4 — Patent

49-62

Inventions; Sections 3, 6, 8, 10, 25, 84; CRI Guidelines.

M5 — Designs

63-68

Industrial designs; Sections 4, 22; Hague Geneva.

M6 — GIs

69-74

600+ Indian GIs; Section 11; cross-cultural protection.

M7 — Trade Secrets

75-81

Confidential information; common law; Section 27 ICA.

M8 — Plant/Biod/TK

82-87

PPV&FR Act 2001; Biological Diversity Act 2002; TKDL.

M9 — Emerging Tech IP

88-94

AI/ML; Blockchain; NFTs; IoT; SEP/FRAND.

M10 — IP Enforcement

95-101

HC IP Divisions; Sections 134, 62, 22, 21; civil + criminal + customs.

M11 — IP Intersections

102-108

IP-Competition; IP-Tax; IP-Constitutional; IP-Insolvency.

M12 — Landmark Cases

109-115

Foundational + recent watershed cases compendium.

M13 — International Framework

116-129

TRIPS + Madrid + PCT + Hague + Marrakesh + Beijing + Berne; WIPO.

M14 — Strategic IP Practice

130-136

IP strategy + future considerations.

M15 — Procedural & Specialised

137-143

Patent + TM + Copyright Office; litigation; specialised practice; comparative.

M16 — Workshop & Practical

144-152

Drafting + prosecution + audit + licensing + NDAs + cease & desist.

M17 — Industry Deep-Dives

153-160

Pharma + Tech + Biotech + FMCG + Banking/FinTech + Healthcare + Education + Master.

6. Comprehensive Practice Strategy

For comprehensive IP practice — full strategy

1. PROCEDURAL EXCELLENCE (M15) · Master 2024 Patents Rules. · Master 2017 Trade Marks Rules. · Master Copyright Rules 2013 + 2012 Amendment. · Track Mediation Act 2023 framework. · Engage HC IP Divisions. 2. WORKSHOP MASTERY (M16) · Patent specification drafting. · Patent prosecution. · TM prosecution. · Copyright workshop. · IP audits + DD. · Licensing + assignment. · NDA + employment. · Cease & desist + enforcement. 3. INDUSTRY EXPERTISE (M17) · Pharmaceutical IP — Section 3(d) + 84 + 107A. · Tech IP — Section 3(k) + CRI 2025 + SEP/FRAND. · Biotechnology IP — Section 3(j) + PPV&FR + BD Act. · FMCG IP — multi-IP integration + GIs. · Banking + FinTech IP — software navigation + crypto. · Healthcare IP — Section 3(i) + medical devices. · Education + EdTech IP — fair dealing + AI. 4. INTERNATIONAL COMPETENCE (M13) · Madrid + PCT + Hague + Marrakesh + Beijing. · TRIPS framework. · Comparative law awareness. · Bilateral cooperation. 5. STRATEGIC THINKING (M14) · Innovation incentivization. · TRIPS flexibility preservation. · South-South cooperation. · Strategic autonomy. 6. ADAPTABILITY · Continuous learning. · Track legal reforms. · Monitor case law evolution. · Engage emerging technologies. · Anticipate future needs.

7. The Legal Bridge IPR Series — Comprehensive Conclusion

The Legal Bridge IPR Series — 160 Topics, 17 Modules COMPLETE

CONGRATULATIONS on completing the COMPREHENSIVE 17-MODULE / 160-TOPIC IP SERIES! WHAT YOU HAVE LEARNED: · 17 modules covering complete Indian IPR. · 160 topics from foundations through industry deep-dives. · Comprehensive operational vocabulary. · Foundational + landmark cases (M12). · Complete statutory framework mastery. · Modern reforms awareness. · International framework competence (M13). · Specialised practice expertise (M15/141). · Comparative IP awareness (M15/142). · Strategic IP thinking (M14). · Workshop + practical skills (M16). · Industry-specific expertise (M17). · Future-aware perspective. FOR JUDICIARY EXAMS: · Comprehensive vocabulary + cases. · All major statutory provisions. · Modern reforms + recent cases. · International framework. · Comparative analysis. · Workshop practical knowledge. · Industry-specific applications. FOR PRACTICE: · Strategic IP integration. · Multi-disciplinary approach. · International coordination. · Specialised expertise. · Workshop practical mastery. · Industry-specific competence. · Future-aware perspective. For The Legal Bridge: · thelegalbridge.in · Wishing success in judiciary preparation! · Wishing success in IP practice! This 17-module / 160-topic series provides the MOST COMPREHENSIVE Indian IPR jurisprudence framework available — from foundational concepts through industry-specific deep-dives. The IP journey from foundations to industry-specific mastery is now complete.

8. Future Considerations

Continued IP Learning Pathway

AFTER COMPLETING 160 TOPICS: 1. KEEP UP WITH ACTIVE DEVELOPMENTS · ANI v. OpenAI 2024 judgment (reserved 2025). · CRI Guidelines 2025 final version. · Income Tax Act 2025 effective 1 April 2026. · DPDP Rules 2025-26. · Continuing case law evolution. 2. SPECIALISED DEEP-DIVES BEYOND M17 · Automotive + Aerospace IP. · Defense IP. · Renewable Energy IP. · Real Estate + Construction IP. · Sports IP standalone. · Mining + Resources IP. · Media + Entertainment depth. · Agriculture IP depth. · Insurance IP. · Logistics + Supply Chain IP. 3. INTERNATIONAL ENGAGEMENT · WIPO meetings + initiatives. · TRIPS Council activities. · Bilateral IP cooperation. · Comparative law studies. 4. PRACTICE INTEGRATION · Workshop application. · Mock drafting exercises. · Case studies. · Mock arguments + hearings. · Real-world case analysis. 5. COMMUNITY ENGAGEMENT · Bar associations. · IP councils. · Patent agent networks. · Trade mark practitioner groups. · Copyright societies. · Industry-specific associations. 6. CONTINUING EDUCATION · Conferences + workshops. · CLE programs. · Online courses. · Research publications. · Academic engagement. · Industry deep-dives. The Legal Bridge will continue providing comprehensive judiciary exam preparation across all major legal subjects. Stay engaged at thelegalbridge.in.

🎯 EXAM POINTERS — TOPIC 160 (M17 Master + Series Closer)

  • Module 17 covers: Pharmaceutical + Tech + Biotech + FMCG + Banking/FinTech + Healthcare + Education industry deep-dives.
  • Pharmaceutical IP: Section 3(d) + 84 + 107A; Novartis 2013; Natco-Bayer 2012; Bayer-UoI 2019; Aventis 2025.
  • Tech IP: Section 3(k) + CRI Guidelines 2025; Ferid Allani 2019; OpenTV 2023; Telefonaktiebolaget v. Lava 2024 ₹244 CRORE.
  • Biotechnology IP: Section 3(j) + PPV&FR 2001 + BD Act 2002; TKDL; Monsanto-Nuziveedu 2019; Nagoya + Cartagena.
  • FMCG IP: Multi-IP framework; ITC-Britannia 2017 trade dress; Pidilite 2024 ₹50L; Cadila + Pernod Ricard; 600+ GIs.
  • Banking + FinTech IP: Section 3(k) navigation; PSS Act 2007; UPI; India Stack; Section 115BBH crypto 30%; RBI v. IMAI 2020.
  • Healthcare IP: Section 3(i) medical methods; D&C Act 1940; Medical Devices Rules 2017; CDSCO; Telemedicine 2020.
  • Education + EdTech IP: Section 52(1)(i) educational fair dealing (Cambridge UP 2016); Marrakesh 2014; Section 17(c) work for hire.
  • Aventis v. Algreat (3 February 2025) — ₹5L + 4 weeks imprisonment.
  • Telefonaktiebolaget v. Lava (2024:DHC:2698; March 2024) — ₹244 CRORE damages.
  • Pidilite v. Premier (2024) — ₹50L damages.
  • Pernod Ricard v. Karanveer (2025 INSC 981) — composite test.
  • Mars v. Cadbury (2025) — Mediation Act 2023 settlement.
  • Cambridge UP v. Rameshwari Photocopy (2016) — educational fair dealing.
  • Stephen Thaler 2025 — AI authorship 8-week directive.
  • ANI v. OpenAI 2024 — judgment reserved 2025.
  • Engineering Analysis 2021 — software royalty taxation.
  • CRI Guidelines 2025 (29 July 2025) — three-step test.
  • DPDP Act 2023 — effective February 2025.
  • Mediation Act 2023 — effective 24 January 2024.
  • Income Tax Act 2025 — effective 1 April 2026.
  • COMPLETE SERIES: 17 modules / 160 topics covering complete Indian IPR jurisprudence including industry-specific deep-dives.
  • India strategic position: TRIPS-compliant + flexibilities-preserving + South-South cooperation + strategic autonomy + industry-leading.